Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy?

Tumori

Volumn 100, Issue 3, 2014, Pages

  Alongi, Filippo ^a   De Bari, Berardino ^b   Scorsetti, Marta ^c  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; CANCER RADIOTHERAPY; COMPARATIVE EFFECTIVENESS; DOSE RESPONSE; DOSIMETRY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LETTER; OUTCOME ASSESSMENT; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION SAFETY; RISK REDUCTION; STEREOTACTIC ABLATIVE RADIATION THERAPY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT INDICATION; BONE NEOPLASMS; ESOPHAGUS; RADIATION RESPONSE; RADIOSURGERY; SECONDARY;

BONE NEOPLASMS; ESOPHAGUS; HUMANS; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 84921643735     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1578.17244     Document Type: Letter

References (13)

1. Leksell D: Radiosurgery. Neurosurgery, 24: 297-298, 1989.
2. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M: Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist, 17: 1100-1107, 2012.
3. Iyengar P, Westover K, Timmerman RD: Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer. Semin Respir Crit Care Med, 34: 845-854, 2013.
4. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science, 300: 1155-1159, 2003. (Pubitemid 36583102)
5. Fuks Z, Kolesnick R: Engaging the vascular component of the tumor response. Cancer Cell, 8: 89-91, 2005. (Pubitemid 41132735)
6. Bekelman JE, Epstein AJ, Emanuel EJ: Single- vs multiplefraction radiotherapy for bone metastases from prostate cancer. JAMA, 310: 1501-1502, 2013.
7. Greco C, Zelefsky MJ, Lovelock M, Fuks Z, Hunt M, Rosenzweig K, Zatcky J, Kim B, Yamada Y: Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys, 79: 1151-1157, 2011.
8. Zelefsky MJ, Greco C, Motzer R, Magsanoc JM, Pei X, Lovelock M, Mechalakos J, Zatcky J, Fuks Z, Yamada Y: Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys, 82: 1744-1748, 2012.
9. Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z: High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys, 71: 484-490, 2008.
10. Osti MF, Carnevale A, Valeriani M, De Sanctis V, Minniti G, Cortesi E, Martelli M, Maurizi Enrici R: Clinical outcomes of single dose stereotactic radiotherapy for lung metastases. Clin Lung Cancer, 14: 699-703, 2013.
11. Wulf J, Baier K, Mueller G, Flentje MP: Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol, 77: 83-87, 2005. (Pubitemid 41503394)
12. Hara R, Itami J, Kondo T, Aruga T, Uno T, Sasano N, Ohnishi K, Kiyozuka M, Fuse M, Ito M, Naoi K, Kohno Y: Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer, 106: 1347-1352, 2006. (Pubitemid 43363913)
13. Cox BW, Jackson A, Hunt M, Bilsky M, Yamada Y: Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys, 83: e661-667, 2012.